The JAM test. A simple assay for DNA fragmentation and cell death - PubMed (original) (raw)
The JAM test. A simple assay for DNA fragmentation and cell death
P Matzinger. J Immunol Methods. 1991.
Abstract
Most current methods for measuring cell death are based on plasma membrane disintegration and the consequent release of cytoplasm. The relevant cells are usually loaded with a label (usually 51Cr or 125I), the release of which is measured. I describe here a method, based on the recent evidence that dying cells often degrade their DNA into small fragments, which measures the DNA retained by living cells rather than the cellular components lost by dying cells. The assay is set up essentially like the current cell lysis assays and harvested like a cell proliferation assay. It is faster, more sensitive, easier to set up, less expensive and safer than the current standard 51Cr release assay.
Similar articles
- The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis.
Usharauli D, Perez-Diez A, Matzinger P. Usharauli D, et al. Nat Protoc. 2006;1(2):672-82. doi: 10.1038/nprot.2006.107. Nat Protoc. 2006. PMID: 17406295 - Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
Wierda WG, Mehr DS, Kim YB. Wierda WG, et al. J Immunol Methods. 1989 Aug 15;122(1):15-24. doi: 10.1016/0022-1759(89)90329-3. J Immunol Methods. 1989. PMID: 2760476 - Apoptosis detection by annexin V binding: a novel method for the quantitation of cell-mediated cytotoxicity.
Shounan Y, Feng X, O'Connell PJ. Shounan Y, et al. J Immunol Methods. 1998 Aug 1;217(1-2):61-70. doi: 10.1016/s0022-1759(98)00090-8. J Immunol Methods. 1998. PMID: 9776575 - The JAM-assay: optimized conditions to determine death-receptor-mediated apoptosis.
Hoves S, Krause SW, Schölmerich J, Fleck M. Hoves S, et al. Methods. 2003 Oct;31(2):127-34. doi: 10.1016/s1046-2023(03)00122-1. Methods. 2003. PMID: 12957570
Cited by
- Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity.
Hossain MK, Vartak A, Sucheck SJ, Wall KA. Hossain MK, et al. ACS Omega. 2019 Mar 31;4(3):5204-5208. doi: 10.1021/acsomega.9b00029. Epub 2019 Mar 13. ACS Omega. 2019. PMID: 30949616 Free PMC article. - Engineered FVIII-expressing cytotoxic T cells target and kill FVIII-specific B cells in vitro and in vivo.
Parvathaneni K, Scott DW. Parvathaneni K, et al. Blood Adv. 2018 Sep 25;2(18):2332-2340. doi: 10.1182/bloodadvances.2018018556. Blood Adv. 2018. PMID: 30232086 Free PMC article. - Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-rhamnose Antibodies.
Hossain MK, Vartak A, Karmakar P, Sucheck SJ, Wall KA. Hossain MK, et al. ACS Chem Biol. 2018 Aug 17;13(8):2130-2142. doi: 10.1021/acschembio.8b00312. Epub 2018 Jul 2. ACS Chem Biol. 2018. PMID: 29916701 Free PMC article. - Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients.
Robinson TM, Prince GT, Thoburn C, Warlick E, Ferguson A, Kasamon YL, Borrello IM, Hess A, Smith BD. Robinson TM, et al. Leuk Lymphoma. 2018 Dec;59(12):2801-2811. doi: 10.1080/10428194.2018.1443449. Epub 2018 Apr 4. Leuk Lymphoma. 2018. PMID: 29616857 Free PMC article. - Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF.
Manrique-Rincón AJ, Beraldo CM, Toscaro JM, Bajgelman MC. Manrique-Rincón AJ, et al. Front Immunol. 2017 Sep 19;8:1150. doi: 10.3389/fimmu.2017.01150. eCollection 2017. Front Immunol. 2017. PMID: 28974950 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources